VICTORY FINANCIAL GROUP, LLC

Position in GSK — GSK plc

CIK 2011333 AUSTIN, TX

Position in GSK

as of Jun 30, 2026 · filed Jul 29, 2026 Compact

Position Value

$613,471

+$195,628 QoQ

Shares Held

11,703

+54.6% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.26%

of 13F equity value

Holder Rank

#437

of 1,032 holders

Holding Since

Sep 2025

4 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

VICTORY FINANCIAL GROUP, LLC holds $10,640,896 across 7 Drug Manufacturers - General names. GSK ranks #6 (5.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	3,281	$3,935,330
2	ABBV	AbbVie Inc.	8,863	$2,230,285
3	JNJ	Johnson & Johnson	7,361	$1,869,473
4	AMGN	Amgen Inc	2,418	$875,606
5	MRK	Merck & Co., Inc.	5,874	$754,809
6	GSK	GSK plc This page	11,703	$613,471
7	PFE	Pfizer Inc	15,030	$361,922

4 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$613,471	11,703	+54.6%	Shares	Sole	2026-07-29
2026-03-31	$417,843	7,571	-28.7%	Shares	Sole	2026-04-27
2025-12-31	$520,657	10,617	+80.4%	Shares	Sole	2026-01-15
2025-09-30	$254,039	5,886	—	Shares	Sole	2025-11-14
No filing history on record for this holder in this stock.